Results 41 to 50 of about 406,081 (396)

Characterizing Recurrence Following Hybrid Ablation in Patients With Persistent Atrial Fibrillation

open access: yesJournal of Patient-Centered Research and Reviews, 2020
Purpose: It is It is widely accepted that atrial fibrillation (AF) accounts for half of arrhythmia recurrences following endocardial catheter ablation of AF.
David C. Kress   +4 more
doaj   +1 more source

Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results

open access: yesCardiovascular Electrophysiology, 2019
This study evaluated the impact of daily ECG (electrocardiogram) self‐recordings on time to documented recurrent atrial fibrillation (AF) or atrial flutter (AFL) and time to treatment of recurrent arrhythmia in patients undergoing catheter radiofrequency
Isaac L Goldenthal   +11 more
semanticscholar   +1 more source

Rapidly detecting disorder in rhythmic biological signals: A spectral entropy measure to identify cardiac arrhythmias [PDF]

open access: yesPhys. Rev. E 79, 011915 (2009), 2008
We consider the use of a running measure of power spectrum disorder to distinguish between the normal sinus rhythm of the heart and two forms of cardiac arrhythmia: atrial fibrillation and atrial flutter. This spectral entropy measure is motivated by characteristic differences in the spectra of beat timings during the three rhythms.
arxiv   +1 more source

What Is the Optimal Digoxin Level? Challenging Case of Fetal Atrial Flutter Treatment in a Monochorionic Diamniotic Twin

open access: yesMedicina, 2023
Background: Atrial flutter is an infrequent yet potentially fatal arrhythmia. Digoxin is the preferred first-line treatment for fetal atrial flutter due to its efficacy and favorable safety profile.
Soo Jung Kim   +5 more
doaj   +1 more source

Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014

open access: yesEuropean Heart Journal, 2018
Aims Risks of catheter ablation for atrial fibrillation and flutter assessed in retrospective studies, registries, and controlled trials may underestimate ‘real world’ conditions.
G. Steinbeck   +5 more
semanticscholar   +1 more source

Selecting Classifiers by Pooling over Cross-Validation Results in More Consistency in Small-Sample Classification of Atrial Flutter Localization [PDF]

open access: yesSIE, 2022, Langkawi, Malaysia, 2022
Selecting learning machines such as classifiers is an important task when using AI in the clinic. K-fold crossvalidation is a practical technique that allows simple inference of such machines. However, the recipe generates many models and does not provide a means to determine the best one.
arxiv  

The incidence and risk factors for new onset atrial fibrillation in the PROSPER study [PDF]

open access: yes, 2011
Aims Atrial fibrillation/flutter (AF) is the most common arrhythmia in older people. It associates with reduced exercise capacity, increased risk of stroke, and mortality. We aimed to determine retrospectively whether pravastatin reduces the incidence of
B. Buckley   +20 more
core   +1 more source

Patient-Specific Identification of Atrial Flutter Vulnerability–A Computational Approach to Reveal Latent Reentry Pathways

open access: yesFrontiers in Physiology, 2019
Atypical atrial flutter (AFlut) is a reentrant arrhythmia which patients frequently develop after ablation for atrial fibrillation (AF). Indeed, substrate modifications during AF ablation can increase the likelihood to develop AFlut and it is clinically ...
A. Loewe   +6 more
semanticscholar   +1 more source

Virtualizing clinical cases of atrial flutter in a fast marching simulation including conduction velocity and ablation scars

open access: yesCurrent Directions in Biomedical Engineering, 2015
Diagnosis of atrial flutter caused by ablation of atrial fibrillation is complex due to ablation scars. This paper presents an approach to replicate the clinically measured flutter circuit in a dynamic computer model.
Trächtler J.   +6 more
doaj   +1 more source

Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or Flutter [PDF]

open access: yes, 1997
Objectives. This study sought to determine the safety and efficacy of a single bolus of intravenous dofetilide, a pure class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter.Background.
Falk, Rodney H.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy